News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Probiodrug AG Strengthens Management Team and Expands Global Reach with Appointments of Ronald Black and Inge Lues


1/23/2013 7:14:57 AM

Probiodrug AG (Probiodrug) today announced the appointment of two senior executives: Ronald Black, M.D., chief medical officer, and Inge Lues, Ph.D., chief development officer. Dr. Black will be based in the United States and will lead the Company’s clinical development strategy and U.S. presence. Dr. Lues will be based in Germany and will be responsible for non-clinical development and ancillary science activities for the Company’s portfolio of anti-pyroglutamated Abeta therapies for the treatment of Alzheimer’s disease.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES